Scarica l'app Stockscreener
102.50
0.14%
-0.14
Pre-mercato:
102.05
-0.45
-0.44%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Boston Scientific Corp Borsa (BSX) Ultime notizie
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Possible Bearish Signals With Boston Scientific Insiders Disposing Stock - ca.finance.yahoo.com
Fund Update: FLPUTNAM INVESTMENT MANAGEMENT CO added 95,234 shares of BOSTON SCIENTIFIC ($BSX) to their portfolio - Quiver Quantitative
3 Reasons Growth Investors Will Love Boston Scientific (BSX) - Yahoo Finance
Boston Scientific Corporation Is Expensive But Worth It - Seeking Alpha
Boston Scientific (NYSE:BSX) Is Experiencing Growth In Returns On Capital - ca.finance.yahoo.com
Boston Scientific updates instructions of devices linked to 17 deaths - MedTech Dive
Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue - Yahoo Finance
FDA says Watchman access alert remedied by review of IFU - BioWorld MedTech
FDA issues alert for updated instructions for certain Boston Scientific Watchman access systems - MassDevice
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths - MSN
Q2 Medical Devices & SuppliesDiversified Earnings: Boston Scientific (NYSE:BSX) Earns Top Marks - ca.finance.yahoo.com
Boston Scientific tells users about defibrillator problem linked to deaths, injuries - MedTech Dive
Oppenheimer Lifts Boston Scientific (BSX) PT to $118 Following Strong Q2 Results - Insider Monkey
Investors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to Know - Yahoo Finance
Boston Scientific survey reveals weight loss struggles among women, launches Endura procedures - MassDevice
Boston Scientific stock falls after FDA discloses defibrillation lead issue - Investing.com
Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions - Yahoo Finance
CMCT Announces 30,821-Square-Foot Lease to Boston Scientific Corporation at Penn Field, a 228,000-Square-Foot Creative Office Campus in Austin - The Globe and Mail
BSX Stock Quote Price and Forecast - CNN
Boston Scientific Corporation Could See a Relief Rally From SupportDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Investing in Boston Scientific (NYSE:BSX) Five Years Ago Would Have Delivered You a 170% Gain - 富途牛牛
Boston Scientific Second Quarter 2025 Earnings: Beats Expectations - ca.finance.yahoo.com
BOSTON SCIENTIFIC CORPORATION (BSX) - MSN
Boston Scientific Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Oppenheimer Adjusts Boston Scientific (BSX) Price Target After Q - GuruFocus
What are the latest earnings results for Boston Scientific CorporationCapitalize on emerging investment opportunities - Jammu Links News
What are Boston Scientific Corporation company’s key revenue driversMarket-beating returns - Jammu Links News
Truist Boosts Boston Scientific (BSX) Price Target After Strong Quarter - Insider Monkey
Chart Analysts Warn of Resistance Near Boston Scientific Corporation PriceGrowth Based Investment Plan Guidance Highlighted - metal.it
Boston Scientific earns Medicare reimbursement for Agent drug-coated balloon - MassDevice
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? - Yahoo Finance
Boston Scientific Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
BOSTON SCIENTIFIC CORP SEC 10-Q Report - TradingView
Boston Scientific Director Fujimori Sells $310,377 Worth of Stock - AInvest
0.62%
1.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):